Bal Pharma Ltd.
BSE: 524824 | Sector: Health care |
NSE: BALPHARMA | ISIN Code: INE083D01012 |
BSE 14:19 | 15 Apr | 63.50 |
0.30 (0.47%) |
OPEN
63.20 |
HIGH
64.70 |
LOW
59.05 |
NSE 14:09 | 15 Apr | 62.75 |
-0.40 (-0.63%) |
OPEN
63.15 |
HIGH
64.80 |
LOW
60.75 |
OPEN | 63.20 |
PREVIOUS CLOSE | 63.20 |
VOLUME | 3951 |
52-Week high | 73.00 |
52-Week low | 33.50 |
P/E | 162.82 |
Mkt Cap.(Rs cr) | 94 |
Buy Price | 62.00 |
Buy Qty | 20.00 |
Sell Price | 63.25 |
Sell Qty | 99.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Profit And Loss
Figures in Rs crore | 2020 | 2019 | 2018 |
Income | |||
Sales Turnover | 170.67 | 223.08 | 209.85 |
Excise Duty | 0.00 | 0.00 | 0.00 |
Net Sales | 170.67 | 223.08 | 209.85 |
Other Income | 3.62 | 2.75 | 1.67 |
Stock Adjustments | -3.32 | 4.41 | 11.24 |
Total Income | 170.97 | 230.24 | 222.76 |
Expenditure | |||
Raw Materials | 80.90 | 121.34 | 111.86 |
Power & Fuel Cost | 4.51 | 6.22 | 5.86 |
Employee Cost | 48.77 | 48.45 | 49.61 |
Other Manufacturing Expenses | 7.24 | 7.35 | 7.68 |
Selling and Administration Expenses | 18.09 | 23.05 | 22.23 |
Miscellaneous Expenses | 0.82 | 0.59 | 0.95 |
less: Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 |
Total Expenditure | 160.33 | 207.00 | 198.19 |
Operating Profit | 10.65 | 23.24 | 24.58 |
Interest | 12.69 | 12.71 | 9.39 |
Gross Profit | -2.04 | 10.53 | 15.19 |
Depreciation | 7.03 | 6.12 | 6.73 |
Profit Before Tax | -9.07 | 4.41 | 8.46 |
Tax | -0.17 | -2.35 | 2.52 |
Net Profit | -8.90 | 6.76 | 5.94 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices